AAAAAA

   
Results: 1-11 |
Results: 11

Authors: STARZYNSKA T WIECHOWSKAKOZLOWSKA A MARLICZ K BROMLEY M ROBERTS SA LAWNICZAK M KOLODZIEJ B ZYLUK A STERN PL
Citation: T. Starzynska et al., 5T4 ONCOFETAL ANTIGEN IN GASTRIC-CARCINOMA AND ITS CLINICAL-SIGNIFICANCE, European journal of gastroenterology & hepatology, 10(6), 1998, pp. 479-484

Authors: STARZYNSKA T BROMLEY M MARLICZ K ROBERTS SA UCINSKI M STERN PL
Citation: T. Starzynska et al., ACCUMULATION OF P53 IN RELATION TO LONG-TERM PROGNOSIS IN COLORECTAL-CARCINOMA, European journal of gastroenterology & hepatology, 9(2), 1997, pp. 183-186

Authors: STARZYNSKA T KOZLOWSKA A MARLICZ K BROMLEY M ROBERTS S LAWNICZAK M KOLODZIEJ B ZYLUK A STERN P
Citation: T. Starzynska et al., THE CLINICAL-SIGNIFICANCE OF 5T4 ANTIGEN IN GASTRIC-CARCINOMA, Gut, 41, 1997, pp. 194-194

Authors: STARZYNSKA T MARLICZ K MARKIEWSKI M NOWAK A HRYNIEWIECKI L BOLDYS H SIPPONEN P STERN P DOMAGALA W
Citation: T. Starzynska et al., P53 TUMOR-SUPPRESSOR PROTEIN IN GASTRIC DYSPLASIA AND EARLY CARCINOMA, Gut, 41, 1997, pp. 256-256

Authors: SCHEIRLE A FRIC P JUHASZ L NOWAK A LONOVICS K MARLICZ K BUTRUK E JIRASEK V DOBRONTE Z DITE P PAPP J
Citation: A. Scheirle et al., CLINICAL SUPERIORITY OF PANTOPRAZOLE VS RANITIDINE IN PATIENTS WITH FLORID DUODENAL-ULCERS, Gastroenterology, 112(4), 1997, pp. 281-281

Authors: GABRYELEWICZ A CZAJKOWSKI A SKRODZKA D MARLICZ K DETENA FL ALDEGUER M CHANTAR C MARQUEZ M TORRES J ORTIZ JA
Citation: A. Gabryelewicz et al., COMPARISON OF THE EFFICACY AND SAFETY OF EBROTIDINE IN THE TREATMENT OF DUODENAL-ULCER - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-II STUDY, Arzneimittel-Forschung, 47-1(4A), 1997, pp. 545-550

Authors: STARZYNSKA T MARKIEWSKI M DOMAGALA W MARLICZ K MIETKIEWSKI J ROBERTS SA STERN PL
Citation: T. Starzynska et al., THE CLINICAL-SIGNIFICANCE OF P53 ACCUMULATION IN GASTRIC-CARCINOMA, Cancer, 77(10), 1996, pp. 2005-2012

Authors: GABRYELEWICZ A KONTUREK SJ BUTRUK E DZIENISZEWSKI J MARLICZ K NOWAK A TORRES J MARQUEZ M ORTIZ JA
Citation: A. Gabryelewicz et al., EFFICACY AND SAFETY OF EBROTIDINE COMPARED WITH RANITIDINE IN PATIENTS WITH DUODENAL-ULCER, European journal of gastroenterology & hepatology, 7(4), 1995, pp. 361-366

Authors: BAILEY RJ MARLICZ K ROSCH W DEMUCKADELL S SCHULZ T THJODLEIFSSON B UNGE P ROBERTS PM
Citation: Rj. Bailey et al., GR122311X (RANITIDINE BISMUTH CITRATE) A NEW DRUG FOR THE TREATMENT OF GASTRIC-ULCER, Gastroenterology, 108(4), 1995, pp. 51-51

Authors: GABRYELEWICZ A KONTUREK SJ BUTRUK G DZIENISZEWSKI J NOWAK A MARLICZ K MARQUEZ W TORRES J ORTIZ JA
Citation: A. Gabryelewicz et al., COMPARISON OF THE EFFICACY AND SAFETY OF EBROTIDINE AND RANITIDINE INTHE TREATMENT OF DUODENAL-ULCER (DU), Gastroenterology, 106(4), 1994, pp. 10000079-10000079

Authors: GABRYELEWICZ A BUTRUK E DZIENISZEWSKI J MARLICZ K NOWAK A KONTUREK SJ TORRES J
Citation: A. Gabryelewicz et al., HEALING OF DUODENAL-ULCER (DU) WITH EBROTIDINE, A NOVEL H2-RECEPTOR ANTAGONIST WITH GASTROPROTECTIVE ACTIVITY, Gastroenterology, 104(4), 1993, pp. 84-84
Risultati: 1-11 |